STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.

DNA sequencing with chain-terminating inhibitors

Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515

Detection of specific sequences among DNA fragments separated by gel electrophoresis

Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,245

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512

“Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A

Burnette, W. N. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90281-5 · Cited by 8,432

Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter

Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7035 · Cited by 6,324

The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains

Hanks, S. K., Quinn, A. M., & Hunter, T. R. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,040

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741

Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Frohman, M. A., Dush, M. K., & Martin, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8998 · Cited by 4,545

Purification and Characterization of Mouse Hematopoietic Stem Cells

Spangrude, G. J., Heimfeld, S., & Weissman, I. L. (1988) · Science · doi:10.1126/science.2898810 · Cited by 2,908

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

Thiede, C., Steudel, C., Mohr, B., Schaich, M. A., Schäkel, U., Platzbecker, U., Wermke, M., Bornhäuser, M., Ritter, M., Neubauer, A., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4326 · Cited by 1,719

The roles of FLT3 in hematopoiesis and leukemia

Gilliland, D. G., & Griffin, J. D. (2002) · Blood · doi:10.1182/blood-2002-02-0492 · Cited by 1,611

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML

Perl, A. E., Martinelli, G., Cortes, J. E., Neubauer, A., Berman, E., Paolini, S., Montesinos, P., Baer, M. R., Larson, R. A., Ustun, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1902688 · Cited by 1,287

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor

Heinrich, M. C., Griffith, D., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,066

Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells

McKenna, H. J., Stocking, K. L., Miller, R. E., Brasel, K., Smedt, T. D., Maraskovsky, E., Maliszewski, C. R., Lynch, D. H., Smith, J., Pulendran, B., et al. (2000) · Blood · doi:10.1182/blood.v95.11.3489 · Cited by 966

The role of FLT3 in haematopoietic malignancies

Stirewalt, D. L., & Radich, J. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1169 · Cited by 865

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., et al. (1999) · PubMed · doi:10.1182/blood.v93.9.3074 · Cited by 747

c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities

Lyman, S. D., & Jacobsen, S. E. W. (1998) · Blood · doi:10.1182/blood.v91.4.1101 · Cited by 686

Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies

Heinrich, M. C., Blanke, C. D., Druker, B. J., & Corless, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1692 · Cited by 630

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

Smith, B. D., Levis, M. J., Beran, M., Giles, F. J., Kantarjian, H. M., Berg, K. D., Murphy, K. M., Dauses, T., Allebach, J., & Small, D. (2004) · Blood · doi:10.1182/blood-2003-11-3775 · Cited by 629

Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways

Mizuki, M., Fenski, R., Halfter, H., Matsumura, I., Schmidt, R., Müller‐Tidow, C., Grüning, W., Kratz‐Albers, K., Serve, S., Steur, C., et al. (2000) · Blood · doi:10.1182/blood.v96.12.3907 · Cited by 599

Flt3 Ligand Regulates Dendritic Cell Development from Flt3+ Lymphoid and Myeloid-committed Progenitors to Flt3+ Dendritic Cells In Vivo

Karsunky, H., Mérad, M., Cozzio, A., Weissman, I. L., & Manz, M. G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030323 · Cited by 594

Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors

Mackarehtschian, K., Hardin, J. D., Moore, K., Boast, S., Goff, S. P., & Lemischka, I. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90167-1 · Cited by 575

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3 –Internal Tandem Duplication Mutation (SORMAIN)

Burchert, A., Bug, G., Fritz, L. V., Finke, J., Stelljes, M., Röllig, C., Wollmer, E., Wäsch, R., Bornhäuser, M., Berg, T., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03345 · Cited by 576

FLT3: ITDoes matter in leukemia

Levis, M. J., & Small, D. (2003) · Leukemia · doi:10.1038/sj.leu.2403099 · Cited by 494

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

Levis, M. J., Allebach, J., Tse, K.-F., Zheng, R., Baldwin, B. R., Smith, B. D., Jones‐Bolin, S., Ruggeri, B., Dionne, C. A., & Small, D. (2002) · Blood · doi:10.1182/blood.v99.11.3885 · Cited by 472

Inhibition of FLT3 in MLL

Armstrong, S. A., Kung, A. L., Mabon, M. E., Silverman, L. B., Stam, R. W., den Boer, M. L., Pieters, R., Kersey, J. H., Sallan, S. E., Fletcher, J. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00003-5 · Cited by 401

Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.

Petzer, A. L., Hogge, D. E., Landsdorp, P. M., Reid, D. S., & Eaves, C. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1470 · Cited by 346

Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemias

Carow, C. E., Levenstein, M. E., Kaufmann, S. H., Chen, J., Amin, S., Rockwell, P., Witte, L., Borowitz, M. J., Civin, C., & Small, D. (1996) · Blood · doi:10.1182/blood.v87.3.1089.bloodjournal8731089 · Cited by 343

STAT3 is required for Flt3L-dependent dendritic cell differentiation

Laouar, Y., Welte, T., Fu, X.-Y., & Flavell, R. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00332-7 · Cited by 334

Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML

Sallmyr, A., Fan, J., Datta, K., Kim, K.-T., Grosu, D., Shapiro, P. S., Small, D., & Rassool, F. V. (2008) · Blood · doi:10.1182/blood-2007-05-092510 · Cited by 330

Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.

Petzer, A. L., Zandstra, P. W., Piret, J. M., & Eaves, C. J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2551 · Cited by 315

FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development

Kiyoi, H., Kawashima, N., & Ishikawa, Y. (2019) · Cancer Science · doi:10.1111/cas.14274 · Cited by 325

FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group

Abuduhier, F. M., Goodeve, A. C., Wilson, G. A., Gari, M. A., Peake, I. R., Rees, D. C., Vandenberghe, E., Winship, P. R., & Reilly, J. T. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02317.x · Cited by 304

Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor

Ueda, T., Tsuji, K., Yoshino, H., Ebihara, Y., Yagasaki, H., Hisakawa, H., Mitsui, T., Manabe, A., Tanaka, R., Kobayashi, K., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8583 · Cited by 279

AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations

Choudhary, C., Schwäble, J., Brandts, C., Tickenbrock, L., Sargin, B., Kindler, T., Fischer, T. H., Berdel, W. E., Müller‐Tidow, C., & Serve, H. L. (2005) · Blood · doi:10.1182/blood-2004-07-2942 · Cited by 272

Nucleic Acid Therapeutics: State of the Art and Future Prospects

Gewirtz, A. M., Sokol, D. L., & Ratajczak, M. Z. (1998) · Blood · doi:10.1182/blood.v92.3.712 · Cited by 249

Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15

Yu, H., Fehniger, T. A., Fuchshuber, P., Thiel, K. S., Vivier, É., Carson, W. E., & Caligiuri, M. A. (1998) · Blood · doi:10.1182/blood.v92.10.3647 · Cited by 234

Flt3-dependent transformation by inactivating c-Cbl mutations in AML

Sargin, B., Choudhary, C., Crosetto, N., Schmidt, M. H. H., Grundler, R., Rensinghoff, M., Thiessen, C., Tickenbrock, L., Schwäble, J., Brandts, C., et al. (2007) · Blood · doi:10.1182/blood-2007-01-066076 · Cited by 220

FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications

Kazi, J. U., & Rönnstrand, L. (2019) · Physiological Reviews · doi:10.1152/physrev.00029.2018 · Cited by 223

In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effects

Levis, M. J., Pham, R., Smith, B. D., & Small, D. (2004) · Blood · doi:10.1182/blood-2004-01-0388 · Cited by 218

Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro

Shah, A. J., Smogorzewska, E. M., Hannum, C. H., & Crooks, G. (1996) · Blood · doi:10.1182/blood.v87.9.3563.bloodjournal8793563 · Cited by 212

FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

Zheng, R., Levis, M. J., Piloto, O., Brown, P. A., Baldwin, B. R., Gorin, N. C., Beran, M., Zhu, Z., Ludwig, D. L., Hicklin, D., et al. (2003) · Blood · doi:10.1182/blood-2003-06-1969 · Cited by 202

Role of FLT3 in leukemia

Gilliland, D. G., & Griffin, J. D. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00003 · Cited by 204

Rare variant associations with plasma protein levels in the UK Biobank

Dhindsa, R. S., Burren, O. S., Sun, B. B., Prins, B. P., Matelska, D., Wheeler, E., Mitchell, J., Oerton, E., Hristova, V. A., Smith, K. R., et al. (2023) · Nature · doi:10.1038/s41586-023-06547-x · Cited by 193

Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation

Tse, K.-F., Mukherjee, G., & Small, D. (2000) · Leukemia · doi:10.1038/sj.leu.2401905 · Cited by 195

FLT3 Ligand Induces the Generation of Functionally Active Dendritic Cells in Mice

Shurin, M. R., Pandharipande, P. P., Zorina, T. D., Haluszczak, C., Subbotin, V. M., Hunter, O. C., Brumfield, A. M., Storkus, W. J., Maraskovsky, E., & Lotze, M. T. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1152 · Cited by 190

Zebrafish and Medaka: new model organisms for modern biomedical research

Lin, C., Chiang, C.-Y., & Tsai, H. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0236-5 · Cited by 180

Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children

Xu, F., Taki, T., Yang, H. W., Hanada, R., Hongo, T., Ohnishi, Kobayashi, M., Bessho, F., Yanagisawa, M., & Hayashi, Y. (1999) · British Journal of Haematology · doi:10.1111/j.1365-2141.1999.01284.x · Cited by 176

Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease

Scheijen, B., & Griffin, J. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205317 · Cited by 173

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Zhou, J., Bi, C., Janakakumara, J. V., Liu, S.-C., Chng, W. J., Tay, K.-G., Poon, L.-F., Xie, Z., Palaniyandi, S., Yu, H., et al. (2009) · Blood · doi:10.1182/blood-2008-05-156422 · Cited by 172

The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond

Wander, S. A., Levis, M. J., & Fathi, A. T. (2014) · Therapeutic Advances in Hematology · doi:10.1177/2040620714532123 · Cited by 166

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

Yee, K. W. H., O'Farrell, A. M., Smolich, B. D., Cherrington, J. M., McMahon, G., Wait, C. L., McGreevey, L. S., Griffith, D., & Heinrich, M. C. (2002) · Blood · doi:10.1182/blood-2002-02-0531 · Cited by 164

Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells

Appel, S., Boehmler, A. M., Grünebach, F., Müller, M., Rupf, A., Weck, M. M., Hartmann, U., Reichardt, V. L., Kanz, L., Brümmendorf, T. H., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0975 · Cited by 163

The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors.

Jacobsen, S. E. W., Okkenhaug, C., Myklebust, J. H., Veiby, O. P., & Lyman, S. D. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1357 · Cited by 161

Thrombopoietin, kit Ligand, and flk2/flt3 Ligand Together Induce Increased Numbers of Primitive Hematopoietic Progenitors From Human CD34+Thy-1+Lin− Cells With Preserved Ability to Engraft SCID-hu Bone

Luens, K. M., Travis, M. A., Chen, B. P., Hill, B. L., Scollay, R. G., & Murray, L. J. (1998) · Blood · doi:10.1182/blood.v91.4.1206 · Cited by 155

FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells

Turner, A., Lin, N., Issarachai, S. S., Lyman, S. D., & Broudy, V. (1996) · Blood · doi:10.1182/blood.v88.9.3383.bloodjournal8893383 · Cited by 154

Novel vaccine development strategies for inducing mucosal immunity

Fukuyama, Y., Tokuhara, D., Kataoka, K., Gilbert, R. S., McGhee, Yuki, Y., Kiyono, H., & Fujihashi, K. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.196 · Cited by 146

Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells

Fenski, Flesch, Serve, Mizuki, Oelmann, Kratz‐Albers, Kienast, Leo, Schwartz, Berdel, et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01831.x · Cited by 146

The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors

Hirayama, F., Lyman, S., Clark, S., & Ogawa, M. (1995) · Blood · doi:10.1182/blood.v85.7.1762.bloodjournal8571762 · Cited by 144

In Vitro Expansion of Hematopoietic Progenitors and Maintenance of Stem Cells: Comparison Between FLT3/FLK-2 Ligand and KIT Ligand

Yonemura, Y., Ku, H. T., Lyman, S. D., & Ogawa, M. (1997) · Blood · doi:10.1182/blood.v89.6.1915 · Cited by 142

FLT3 Ligand Preserves the Ability of Human CD34+ Progenitors to Sustain Long-Term Hematopoiesis in Immune-Deficient Mice After Ex Vivo Retroviral-Mediated Transduction

Dao, M. A., Hannum, C. H., Kohn, D. B., & Nolta, J. A. (1997) · Blood · doi:10.1182/blood.v89.2.446 · Cited by 141

Expression profiling of CD34 + hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia

Qian, Z., Fernald, A. A., Godley, L. A., Larson, R. A., & Beau, M. M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222491799 · Cited by 139

Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptor

Breitenbuecher, F., Schnittger, S., Grundler, R., Markova, B., Carius, B., Brecht, A., Duyster, J., Haferlach, T., Huber, C., & Fischer, T. H. (2008) · Blood · doi:10.1182/blood-2007-11-125476 · Cited by 138

Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells

McKenna, H. J., de Vries, P., Brasel, K., Lyman, S. D., & Williams, D. E. (1995) · Blood · doi:10.1182/blood.v86.9.3413.bloodjournal8693413 · Cited by 138

Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells

Zeigler, F., Bennett, B., Jordan, C. T., Spencer, S., Baumhueter, S., Carroll, K., Hooley, J., Bauer, K., & Matthews, W. (1994) · Blood · doi:10.1182/blood.v84.8.2422.2422 · Cited by 137

Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax

Lisovsky, M. Y., Estrov, Z. E., Zhang, X., Consoli, U., Sanchez‐Williams, G., Snell, V., Munker, R., Goodacre, A., Vg, S., & Andreeff, M. (1996) · Blood · doi:10.1182/blood.v88.10.3987.bloodjournal88103987 · Cited by 136

Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia

Swords, R. T., Freeman, C. L. L., & Giles, F. J. (2012) · Leukemia · doi:10.1038/leu.2012.114 · Cited by 138

Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division

Keller, J. R., Ortiz, M., & Ruscetti, F. (1995) · Blood · doi:10.1182/blood.v86.5.1757.bloodjournal8651757 · Cited by 130

Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model

Li, L., Piloto, O., Nguyen, H. B., Greenberg, K. E., Takamiya, K., Racke, F. K., Huso, D. L., & Small, D. (2008) · Blood · doi:10.1182/blood-2007-08-109942 · Cited by 135

Gastric GI stromal tumors (GISTs): The role of surgery in the era of targeted therapy

Heinrich, M. C., & Corless, C. L. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20230 · Cited by 129

The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro

Rusten, L., Lyman, S. D., Veiby, O., & Jacobsen, S. E. W. (1996) · Blood · doi:10.1182/blood.v87.4.1317.bloodjournal8741317 · Cited by 129

Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.

Rappold, I., ZIEGLER, B. L., Köhler, I., Marchetto, S., Rosnet, O., Birnbaum, D., Simmons, P. J., Zannettino, A. C. W., Hill, B. L., Neu, S., et al. (1997) · PubMed · doi:10.1182/blood.v90.1.111 · Cited by 127

The Cytokine Flt3-Ligand in Normal and Malignant Hematopoiesis

Tsapogas, P., Mooney, C. J., Brown, G., & Rolink, A. G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061115 · Cited by 137

Analysis of KIT Mutations in Sporadic and Familial Gastrointestinal Stromal Tumors: Therapeutic Implications through Protein Modeling

Tarn, C., Merkel, E., Canutescu, A. A., Shen, W., Skorobogatko, Y. V., Heslin, M. J., Eisenberg, B. L., Birbe, R., Patchefsky, A. S., Dunbrack, R. L., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2515 · Cited by 120

Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia

Wodnar-Filipowicz, A., Lyman, S. D., Gratwohl, A. A., Tichelli, A., SPECK, B., & Nissen, C. (1996) · Blood · doi:10.1182/blood.v88.12.4493.bloodjournal88124493 · Cited by 118

FMS-Like Tyrosine Kinase 3 in Normal Hematopoiesis and Acute Myeloid Leukemia

Parcells, B. W., Ikeda, A. K., Simms-Waldrip, T. R., Moore, T. B., & Sakamoto, K. M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0519 · Cited by 117

Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy

Boissel, N., Cayuela, J., Preudhomme, C., Thomas, X., Grardel, N., Fund, X., Tigaud, I., Raffoux, E., Rousselot, P. H., Sigaux, F., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402622 · Cited by 117

Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor

Tse, K.-F., Novelli, E. M., Civin, C., Böhmer, F., & Small, D. (2001) · Leukemia · doi:10.1038/sj.leu.2402199 · Cited by 115

Stem Cell Factor as a Survival and Growth Factor in Human Normal and Malignant Hematopoiesis

Hassan, H. T., & Zander, A. (2009) · Acta Haematologica · doi:10.1159/000203893 · Cited by 114

Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors

Williams, A. B., Nguyen, B., Li, L., Brown, P. A., Levis, M. J., Leahy, D. J., & Small, D. (2012) · Leukemia · doi:10.1038/leu.2012.191 · Cited by 113

Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia

Lyman, S. D., Seaberg, M. A., Hanna, R., Zappone, J., Brasel, K., Abkowitz, J., Prchal, J., Schultz, J., & Shahidi, N. (1995) · Blood · doi:10.1182/blood.v86.11.4091.bloodjournal86114091 · Cited by 113

FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units

Hudak, S., Hunte, B., Culpepper, J., Menon, S., Hannum, C. H., Thompson-Snipes, L., & Rennick, D. M. (1995) · Blood · doi:10.1182/blood.v85.10.2747.bloodjournal85102747 · Cited by 113

Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors

Testa, U., Fossati, C., Samoggia, P., Masciulli, R., Mariani, G., Hassan, H. J., Sposi, N. M., Guerriero, R., Rosato, V., Gabbianelli, M., et al. (1996) · Blood · doi:10.1182/blood.v88.9.3391.bloodjournal8893391 · Cited by 108

Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis

Juurikivi, A., Sandler, C., Lindstedt, K. A., Kovanen, P. T., Juutilainen, T., Leskinen, M. J., Mäki, T., & Eklund, K. K. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029835 · Cited by 103

Cytokines and their effects on maturation, differentiation and migration of dendritic cells

Jonuleit, H., Knop, J. X. F. R., & Enk, A. (1996) · Archives of Dermatological Research · doi:10.1007/s004030050144 · Cited by 102

Regulation of hematopoietic stem cell fate

Krause, D. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205316 · Cited by 101

Increased Recruitment of Hematopoietic Progenitor Cells Underlies the Ex Vivo Expansion Potential of FLT3 Ligand

Haylock, D. N., Horsfall, M. J., Dowse, T. L., Ramshaw, H. S., Niutta, S., Protopsaltis, S., Peng, L. J., Burrell, C. J., Rappold, I., Bühring, H., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2260 · Cited by 100

Flt3 Ligand Synergizes With Granulocyte-Macrophage Colony-Stimulating Factor or Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Progenitor Cells Into the Peripheral Blood of Mice

Brasel, K., McKenna, H. J., Charrier, K., Morrissey, P. J., Williams, D. E., & Lyman, S. D. (1997) · Blood · doi:10.1182/blood.v90.9.3781 · Cited by 96

FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver

Muench, M. O., Roncarolo, M., Menon, S., Xu, Y., Kastelein, R., Zurawski, S., Hannum, C., Culpepper, J., Lee, F., & Namikawa, R. (1995) · Blood · doi:10.1182/blood.v85.4.963.bloodjournal854963 · Cited by 94

Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

Eguchi, M., Minami, Y., Kuzume, A., & Chi, S. (2020) · Biomedicines · doi:10.3390/biomedicines8080245 · Cited by 96

Immunolocalization of mitsugumin29 in developing skeletal muscle and effects of the protein expressed in amphibian embryonic cells

Komazaki, S., Nishi, M., Kangawa, K., & Takeshima, H. (1999) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199906)215:2 · Cited by 28

Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution

Gammaitoni, L., Bruno, S., Sanavio, F., Gunetti, M., Kollet, Ó., Cavalloni, G., Falda, M., Fagioli, F., Lapidot, T., Aglietta, M., et al. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(02)01077-9 · Cited by 93

Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor

Tse, K.-F., Allebach, J. P., Levis, M. J., Smith, B., Böhmer, F. D., & Small, D. (2002) · Leukemia · doi:10.1038/sj.leu.2402674 · Cited by 92

Inhibition of CD40 expression and CD40‐mediated dendritic cell function by tumor‐derived IL‐10

Shurin, M. R., Yurkovetsky, Z. R., Tourkova, I. L., Balkir, L., & Shurin, G. V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10576 · Cited by 92

The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells

Colucci, F., & Santo, J. P. D. (2000) · Blood · doi:10.1182/blood.v95.3.984.003k40_984_991 · Cited by 91

Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables

Hennemann, B., Conneally, E., Pawliuk, R., Leboulch, P., Rose‐John, S., Reid, D., Chuo, J. Y., Humphries, R. K., & Eaves, C. J. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00021-1 · Cited by 90

CD34-positive cells: biology and clinical relevance.

Cc, S., Cazzola, M., de Fabritiis, P., De Vincentiis, A., Am, G., Lanza, F., Lauria, F., Lemoli, R. M., Tarella, C., & Zanon, P. (1995) · PubMed · Cited by 88

Targeting FLT3 for the Treatment of Leukemia

Small, D. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.07.007 · Cited by 87

Role of vascular endothelial growth factor (VEGF) and placenta‐derived growth factor (PlGF) in regulating human haemopoietic cell growth

Ratajczak, M. Z., Ratajczak, J., Machaliński, B., Majka, M., Marlicz, W. M., Carter, A., Pietrzkowski, Z. J., & Gswirtz, A. M. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01076.x · Cited by 87

Signal Transduction of Oncogenic Flt3

Choudhary, C., Müller‐Tidow, C., Berdel, W. E., & Serve, H. L. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05090 · Cited by 87

Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations

Zheng, R., Friedman, A. D., & Small, D. (2002) · Blood · doi:10.1182/blood-2002-03-0936 · Cited by 86

FLT3: Receptor and Ligand. Biology and Potential Clinical Application

Shurin, M. R. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00035-x · Cited by 84

Expression and Signal Transduction of the FLT3 Tyrosine Kinase Receptor

Rosnet, O., Bühring, H., deLapeyrière, O., Beslu, N., Lavagna, C., Marchetto, S., Rappold, I., Drexler, H. G., Birg, F., Rottapel, R. K., et al. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0391-6_44 · Cited by 84

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

Rücker, F. G., Du, L., Luck, T. J., Benner, A., Krzykalla, J., Gathmann, I., Voso, M. T., Amadori, S., Prior, T. W., Brandwein, J. M., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01323-0 · Cited by 82

ARP, A Peptide Derived from the Stress-Associated Acetylcholinesterase Variant, Has Hematopoietic Growth Promoting Activities

Grisaru, D., Deutsch, V. R., Shapira, M., Pick, M., Sternfeld, M., Melamed‐Book, N., Kaufer, D., Galyam, N., Gait, M. J., Owen, D. J., et al. (2001) · Molecular Medicine · doi:10.1007/bf03401943 · Cited by 83

The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal- cell-independent expansion and differentiation of human fetal pro-B cells in vitro

Namikawa, R., MO, M., de Vries, J. E., & Roncarolo, M. (1996) · Blood · doi:10.1182/blood.v87.5.1881.1881 · Cited by 83

The molecular pathogenesis of acute myeloid leukemia

Steffen, B., Müller‐Tidow, C., Schwäble, J., Berdel, W. E., & Serve, H. L. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.10.012 · Cited by 85

Combined signaling through interleukin-7 receptors and flt3 but not c- kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells

Veiby, O., Lyman, S. D., & Jacobsen, S. E. W. (1996) · Blood · doi:10.1182/blood.v88.4.1256.bloodjournal8841256 · Cited by 80

TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment

Tabe, Y., Shi, Y. X., Zeng, Z., Jin, L., Shikami, M., Hatanaka, Y., Miida, T., Hsu, F. J., Andreeff, M., & Konopleva, M. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062785 · Cited by 80

FLT3/FLK‐2 (STK‐1) Ligand Does Not Stimulate Human Megakaryopoiesis In Vitro

Ratajczak, M. Z., Ratajczak, J., Ford, J. C., Kregenow, R., Marlicz, W. M., & Gewirtz, A. M. (1996) · Stem Cells · doi:10.1002/stem.140146 · Cited by 22

Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells

Zeigler, F., Bennett, B., Jordan, C. T., Spencer, S., Baumhueter, S., Carroll, K., Hooley, J., Bauer, K., & Matthews, W. (1994) · Blood · doi:10.1182/blood.v84.8.2422.2422 · Cited by 137

Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells

Iwama, A., Okano, K., Sudo, T., Matsuda, Y., & Suda, T. (1994) · Blood · doi:10.1182/blood.v83.11.3160.3160 · Cited by 143

A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations

Matthews, W., Jordan, C. T., Wiegand, G. W., Pardoll, D., & Lemischka, I. R. (1991) · Cell · doi:10.1016/0092-8674(91)90010-v · Cited by 593

A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.

Matthews, W., Jordan, C. T., Gavin, M. A., Jenkins, N. A., Copeland, N. G., & Lemischka, I. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9026 · Cited by 502